Terms: = Endocrine gland cancer AND CREBBP, CBP, 1387, ENSG00000005339, RSTS, RTS AND Treatment
49 results:
1. A multicenter, randomized phase 2 study to establish combinations of cbp501, cisplatin and nivolumab for ≥3rd-line treatment of patients with advanced pancreatic adenocarcinoma.
Enzler T; Nguyen A; Misleh J; Cline VJ; Johns M; Shumway N; Paulson S; Siegel R; Larson T; Messersmith W; Richards D; Chaves J; Pierce E; Zalupski M; Sahai V; Orr D; Ruste SA; Haun A; Kawabe T
Eur J Cancer; 2024 Apr; 201():113950. PubMed ID: 38422585
[TBL] [Abstract] [Full Text] [Related]
2. MiRNA-mRNA integrative analysis reveals epigenetically regulated and prognostic miR-103a with a role in migration and invasion of carboplatin-resistant ovarian cancer cells that acquired mesenchymal-like phenotype.
Pernar Kovač M; Tadić V; Kralj J; Milković Periša M; Orešković S; Babić I; Banović V; Zhang W; Culig Z; Brozovic A
Biomed Pharmacother; 2023 Oct; 166():115349. PubMed ID: 37634476
[TBL] [Abstract] [Full Text] [Related]
3. Retroperitoneal tumour resection in fifteen consecutive cases: Single centre experience.
Novotný R; Donátová Z; Büchler T; Kristek J; Froněk J; Janousek L
Rozhl Chir; 2023; 102(4):154-158. PubMed ID: 37344195
[TBL] [Abstract] [Full Text] [Related]
4. Genetic analysis for mucinous ovarian carcinoma with infiltrative and expansile invasion and mucinous borderline tumor: a retrospective analysis.
Hada T; Miyamoto M; Ohtsuka Y; Suminokura J; Ito T; Kishimoto N; Nishitani S; Takada M; Imauji A; Tanabe R; Takano M
Diagn Pathol; 2023 Apr; 18(1):49. PubMed ID: 37081552
[TBL] [Abstract] [Full Text] [Related]
5. Establishment and Molecular Characterization of Two Patient-Derived Pancreatic Ductal Adenocarcinoma Cell Lines as Preclinical Models for treatment Response.
Braun R; Lapshyna O; Watzelt J; Drenckhan M; Künstner A; Färber B; Hael AAM; Bolm L; Honselmann KC; Konukiewitz B; Castven D; Spielmann M; Gorantla SP; Busch H; Marquardt JU; Keck T; Wellner UF; Ungefroren H
Cells; 2023 Feb; 12(4):. PubMed ID: 36831254
[TBL] [Abstract] [Full Text] [Related]
6. Next-generation sequencing shows the genomic features of ovarian clear cell cancer and compares the genetic architectures of high-grade serous ovarian cancer and clear cell carcinoma in ovarian and endometrial tissues.
Gan M; Tai Z; Yu Y; Zhang C; Xu J
PeerJ; 2023; 11():e14653. PubMed ID: 36721777
[TBL] [Abstract] [Full Text] [Related]
7. In high-grade ovarian carcinoma, platinum-sensitive tumor recurrence and acquired-resistance derive from quiescent residual cancer cells that overexpress CRYAB, CEACAM6, and SOX2.
du Manoir S; Delpech H; Orsetti B; Jacot W; Pirot N; Noel J; Colombo PE; Sardet C; Theillet C
J Pathol; 2022 Jul; 257(3):367-378. PubMed ID: 35302657
[TBL] [Abstract] [Full Text] [Related]
8. Design, synthesis and biological evaluation of a novel spiro oxazolidinedione as potent p300/cbp HAT inhibitor for the treatment of ovarian cancer.
Ding H; Pei Y; Li Y; Xu W; Mei L; Hou Z; Guang Y; Cao L; Li P; Cao H; Bian J; Chen K; Luo C; Zhou B; Zhang T; Li Z; Yang Y
Bioorg Med Chem; 2021 Dec; 52():116512. PubMed ID: 34801827
[TBL] [Abstract] [Full Text] [Related]
9. C646 inhibits G2/M cell cycle-related proteins and potentiates anti-tumor effects in pancreatic cancer.
Ono H; Kato T; Murase Y; Nakamura Y; Ishikawa Y; Watanabe S; Akahoshi K; Ogura T; Ogawa K; Ban D; Kudo A; Akiyama Y; Tanaka S; Ito H; Tanabe M
Sci Rep; 2021 May; 11(1):10078. PubMed ID: 33980911
[TBL] [Abstract] [Full Text] [Related]
10. Celiac Plexus Block Complications: A Case Report and Review of the Literature.
Gupta R; Madanat L; Jindal V; Gaikazian S
J Palliat Med; 2021 Sep; 24(9):1409-1412. PubMed ID: 33395560
[TBL] [Abstract] [Full Text] [Related]
11. Distinguishing Patients With Distant Metastatic Differentiated Thyroid cancer Who Biochemically Benefit From Next Radioiodine treatment.
Sa R; Cheng L; Jin Y; Fu H; Shen Y; Chen L
Front Endocrinol (Lausanne); 2020; 11():587315. PubMed ID: 33304320
[TBL] [Abstract] [Full Text] [Related]
12. Clinicopathological correlation of radiologic measurement of post-therapy tumor size and tumor volume for pancreatic ductal adenocarcinoma.
Wei D; Zaid MM; Katz MH; Prakash LR; Kim M; Tzeng CD; Lee JE; Agrawal A; Rashid A; Wang H; Varadhachary G; Wolff RA; Tamm EP; Bhosale PR; Maitra A; Koay EJ; Wang H
Pancreatology; 2021 Jan; 21(1):200-207. PubMed ID: 33221151
[TBL] [Abstract] [Full Text] [Related]
13. Comparison of the short-term efficacy and serum markers between lobaplatin/paclitaxel- And carboplatin/paclitaxel-based adjuvant chemotherapy in patient with ovarian cancer.
Wang W; Liu M; Ding B
J Clin Pharm Ther; 2021 Feb; 46(1):166-172. PubMed ID: 33098169
[TBL] [Abstract] [Full Text] [Related]
14. Methylation-mediated LINC00261 suppresses pancreatic cancer progression by epigenetically inhibiting c-Myc transcription.
Liu S; Zheng Y; Zhang Y; Zhang J; Xie F; Guo S; Gu J; Yang J; Zheng P; Lai J; Yin L; Wang H
Theranostics; 2020; 10(23):10634-10651. PubMed ID: 32929371
[No Abstract] [Full Text] [Related]
15. 1-MT inhibits the invasion of cbp-resistant ovarian cancer cells via down-regulating IDO expression and re-activating immune cells function.
Ma H; Qin Q; Mi J; Feng Q
BMC Pharmacol Toxicol; 2020 Sep; 21(1):67. PubMed ID: 32912307
[TBL] [Abstract] [Full Text] [Related]
16. Cross‑validation of genes potentially associated with neoadjuvant chemotherapy and platinum‑based chemoresistance in epithelial ovarian carcinoma.
Zhang K; Wang W; Chen L; Liu Y; Hu J; Guo F; Tian W; Wang Y; Xue F
Oncol Rep; 2020 Sep; 44(3):909-926. PubMed ID: 32705213
[TBL] [Abstract] [Full Text] [Related]
17. Acetylation promotes BCAT2 degradation to suppress BCAA catabolism and pancreatic cancer growth.
Lei MZ; Li XX; Zhang Y; Li JT; Zhang F; Wang YP; Yin M; Qu J; Lei QY
Signal Transduct Target Ther; 2020 May; 5(1):70. PubMed ID: 32467562
[TBL] [Abstract] [Full Text] [Related]
18. USP48 Sustains Chemoresistance and Metastasis in Ovarian cancer.
Lei X; Li X; Chen H; Liu Z
Curr Cancer Drug Targets; 2020; 20(9):689-699. PubMed ID: 32359336
[TBL] [Abstract] [Full Text] [Related]
19. A qualitative transcriptional prognostic signature for patients with stage I-II pancreatic ductal adenocarcinoma.
Huang H; Zou Y; Zhang H; Li X; Li Y; Deng X; Sun H; Guo Z; Ao L
Transl Res; 2020 May; 219():30-44. PubMed ID: 32119844
[TBL] [Abstract] [Full Text] [Related]
20. Loss of RBMS3 Confers Platinum Resistance in Epithelial Ovarian cancer via Activation of miR-126-5p/β-catenin/cbp signaling.
Wu G; Cao L; Zhu J; Tan Z; Tang M; Li Z; Hu Y; Yu R; Zhang S; Song L; Li J
Clin Cancer Res; 2019 Feb; 25(3):1022-1035. PubMed ID: 30279231
[TBL] [Abstract] [Full Text] [Related]
[Next]